News alert: The US has pledged as much as $1.2 billion to get early access to 300 million doses of an experimental COVID-19 vaccine

Klicken Sie hier, um Usatoday.com zu abonnieren

Laden...

4 jahre vor

Html
Text

News Alert Thursday, May 21

The US has pledged as much as $1.2 billion to get early access to 300 million doses of an experimental COVID-19 vaccine

A possible coronavirus vaccine being developed by the University of Oxford and licensed to British drugmaker AstraZeneca got the United States' largest vote of confidence to date in terms of funds pledged. The vaccine could be delivered as early as October, though that only means the doses will be stored until the vaccine completes clinical trials ensuring it is safe and effective in protecting against COVID-19 infection.

Problem viewing email? View in browser

Unsubscribe • Manage Newsletters • Terms of Service • Privacy Policy/Your California Privacy Rights • Privacy Notice • Do Not Sell My Info/Cookie Policy • Feedback

Teilen auf

Laden...

Weitere Newsletter von Usatoday.com

Laden...

News alert: The US has pledged as much as $1.2 billion to get early access to 300 million doses of an experimental COVID-19 vaccine

Teilen auf

Weitere Newsletter von Usatoday.com

Verwandte Newsletter